BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SeraCare Life Sciences, Inc. (SRLS) Introduces New Executives


4/24/2012 12:28:13 PM

Milford, MA (PRWEB) April 24, 2012 -- SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that Charlie Mamrak joined the company as CEO and Harold (Bud) Ingalls has joined as CFO. Both executives bring extensive experience in the biosciences industry and a vision for SeraCare to drive the growth of precision medicine by enabling customized testing and individualized diagnoses based on each patient’s specific genetic profile.

“SeraCare already delivers the ingredients necessary to build accurate diagnostic tests and optimize the performance of laboratory assays,” said Charlie Mamrak, chief executive officer at SeraCare. “This company sits at the edge of an immense industry shift and is well positioned to become a driving force behind precision medicine. I am extremely excited to join SeraCare and help steer the organization through this growth.”

Fran Lunger, former CEO of Millipore Corporation, has been named SeraCare Board Chairman while Bill Drehkoff and Brian Miller of Linden, LLC will also join the SeraCare Board. Prior to joining SeraCare, Mr. Mamrak was CEO of PML Microbiologicals, a leading provider of prepared culture media, stains, reagents, quality control organisms, sterility products and collection systems. Mr. Ingalls brings more than 20 years experience in senior management including president and CEO of the start-up stem cell tools company ArunA Biomedical and positions as CFO of Premier Exhibitions and CardioMEMS.

About SeraCare Life Sciences, Inc.

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES